Tempus is a biotechnology company based in New York, New York, specializing in the integration of clinical and molecular data to advance healthcare. Located at 230 Park Avenue, Suite 935, Tempus focuses on developing sophisticated data-driven solutions to support precision medicine, particularly in oncology. The company’s work involves assembling and analyzing vast amounts of clinical and genomic information to assist medical professionals in making more informed treatment decisions.

At the core of Tempus’s operations is a comprehensive data platform that aggregates a wide variety of clinical and molecular datasets. This platform is designed to streamline the process of accessing and interpreting complex medical information, enabling researchers and clinicians to leverage data for improved patient outcomes. By combining technology with scientific expertise, Tempus aims to bridge the gap between raw data and actionable insights within the biotechnology landscape.

Tempus’s efforts extend to collaborating with healthcare providers, researchers, and pharmaceutical companies to enhance the understanding of diseases and tailor treatments to individual patients. Its approach supports ongoing advancements in precision medicine by facilitating the use of real-world data in clinical settings. The company’s location in New York places it at the center of a dynamic biotech ecosystem, contributing to innovation in the life sciences sector.

With a focus on harnessing data for clinical impact, Tempus continues to develop tools and resources that address the challenges of modern medicine. Its commitment to making complex data accessible reflects the growing importance of biotechnology companies in transforming healthcare through technology and analytics. For inquiries, Tempus can be reached at 833-514-4187.